Larvol Delta - Antios-Therapeutics-and-Arbutus-Biopharma-Announce-First-Patient-Dosed-in-Phase-2a-Combination-Trial-of-ATI2173-AB729-and-Tenofovir-Disoproxil-Fumarate-in-Patients-with-Chronic-Hepatitis-B-Virus-Infection

AB-729 - Arbutus

ATI-2173 - Antios Therap

tenofovir disoproxil fumarate - Generic mfg.

https://www.globenewswire.com/news-release/2021/12/14/2351572/14025/en/Antios-Therapeutics-and-Arbutus-Biopharma-Announce-First-Patient-Dosed-in-Phase-2a-Combination-Trial-of-ATI-2173-AB-729-and-Tenofovir-Disoproxil-Fumarate-in-Patients-with-Chronic-H.html

Dec 14, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next